3654 results for «333»

Filter By

3654 results

STEMI Vignettes - The global classroom

18 May 2023 – From EuroPCR 2023

Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.

STEMI Vignettes - The global classroom

Treatment of in-stent restenosis

16 May 2023 – From EuroPCR 2023

Looking for a recap of this case-based session to refresh your memory? Don't miss these slides and review the diagnostic and management details of each case.

In-stent restenosis case

Endovascular management treatment

17 May 2023 – From EuroPCR 2023

In this series of resources, explore the toolbox for BTK bifurcation treatment with antegrade and retrograde management, navigate complex scenarios in superficial femoral artery and femoral bifurcation and  elevate your expertise in carotid artery stenting managment. 

Endovascular management treatment

Mitral and tricuspid valve intervention : new devices and clinical outcomes

17 May 2023 – From EuroPCR 2023

Need a reminder on this session about the new devices and clinical outcomes in mitral and tricuspid valve intervention? Take a look at these slides and review the essential in a glance.

Mitral and tricuspid valve intervention

Bifurcations

17 May 2023 – From EuroPCR 2023

Seeking to revive your understanding of this session focusing on bifurcations? Examine these slides and review the main elements of the presentations.

Bifurcations in interventional cardiology

Working in the cathlab makes everyday different

17 May 2023 – From EuroPCR 2023

Experience the dynamic cathlab environment, where each day brings unique challenges. These slides will cover diverse topics such as pulmonary ductus arteriosus, coronary artery fistula, TAVI with mechanical mitral valve, and much more!

Working in the cathlab makes everyday different

Novel treatment strategies in ACS patients

17 May 2023 – From EuroPCR 2023

Seeking to revive your understanding on novel strategies in ACS treatment? Explore this collection of resources to get insight on optimal antithrombotic therapy in AF patients post-PCI, complete revascularisation in ACS, and early invasive approaches in high-risk NSTEMI, among other topics. 

Novel treatment strategies in ACS patients

Coronary artery disease: more imaging, less imagination

18 May 2023 – From EuroPCR 2023

In these slides, explore associations between angiography-based FFR and OCT-detected luminal obstruction, prognostic impact of ischaemia vs. plaque vulnerability, CT's mortality foresight, and much more.

Coronary artery disease: more imaging, less imagination

TAVI 1: durability, mismatch and challenging anatomy

18 May 2023 – From EuroPCR 2023

Explore TAVI longevity: Five-year Portico valve outcomes, bioprosthetic dysfunction post-surgery or self-expanding TAVI, prosthesis-patient mismatch impact, and innovative valve-in-valve TAVI insights, and more.

TAVI 1: durability, mismatch and challenging anatomy

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

Dynamx bioadaptor restores rotational motion and vessel stress reduction in new study

02 Jun 2022

Elixir Medical completes enrollment in BIOADAPTOR randomized controlled trial of Dynamx Coronary Bioadaptor System

15 Feb 2022

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II: Two-year outcomes of transcatheter tricuspid valve replacement for severe tricuspid regurgitation

31 Mar 2026

Jonathan Curio provides his take on TRISCEND II trial results presented by Vinod H. Thourani at ACC.26 in New Orleans.

Jonathan Curio

Author

Jonathan Curio
TRISCEND II: Two-Year Outcomes Of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation
Didn’t find what you were looking for?